Diagnosis, treatment, and associated outcomes of later-life insomnia: a narrative review
Related Experiment Video
Updated: Sep 15, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Christopher N Kaufmann1, Soomi Lee2, Amy S Berkley3
1Department of Health Outcomes and Biomedical Informatics, University of Florida College of Medicine, 1889 Museum Road, Suite 7000, Gainesville, FL, 32611, USA.
Abstract:
Insomnia is highly prevalent in older adults and is associated with a range of health outcomes. Over the past 10 years, there have been several reviews of the literature concerning insomnia and its outcomes among older individuals; however, there is a need for an updated review examining the emerging themes of research in this space to guide clinical practice and research. Accordingly, in this narrative review, we highlight recent research on insomnia in older adults, documenting the evolution of knowledge regarding insomnia and its consequences as people age. Our review describes trends in the prevalence of insomnia and related symptoms in older adults, as well as potential factors contributing to these trends. We also highlight the growing recognition of insomnia-associated outcomes, specifically focusing on brain and heart health. Given challenges in and barriers to identifying and ultimately treating insomnia, we describe shifts in the ways insomnia is treated with applicability to older adults, including through digital therapeutic modalities that have the potential to increase access to evidence-based behavioral therapies. Our review highlights significant advancements in the understanding of insomnia's role in older adults' health and underscores critical priorities for future research. Statement of Significance Insomnia is highly prevalent in older adults and is associated with a growing scope of adverse health outcomes. While barriers exist to its diagnosis and appropriate treatment in older persons, advancements in the field of sleep medicine, such as expanded pharmacological options and digital therapeutics for behavioral sleep treatments, may help address the unmet need for care. Our narrative review seeks to trace these developments in the hopes of spurring future research to address insomnia in the growing population of older adults.
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Narcolepsy
Blind Procedures

